Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 48 Records) |
Query Trace: Colorectal Neoplasms and TYMS[original query] |
---|
ERCC1 C118T associates with response to FOLFOX4 chemotherapy in colorectal cancer patients in Han Chinese. International journal of clinical and experimental medicine 2012 5 (2): 186-94. Chai Haina, Pan Jie, Zhang Xuelin, Zhang Xiaoyan, Shen Xiaoying, Li Hang, Zhang Kehao, Yang Changqing, Sheng Haihui, Gao Hengj |
Association of dietary and supplemental folate intake and polymorphisms in three FOCM pathway genes with colorectal cancer in a population-based case-control study. Genes, chromosomes & cancer 2013 Oct 52 (10): 945-53. Ashmore Joseph H, Lesko Samuel M, Muscat Joshua E, Gallagher Carla J, Berg Arthur S, Miller Paige E, Hartman Terryl J, Lazarus Phil |
DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity. Cancer chemotherapy and pharmacology 2013 Aug 72 (2): 483-8. Rumiato Enrica, Boldrin Elisa, Amadori Alberto, Saggioro Danie |
Folate-genetics and colorectal neoplasia: what we know and need to know next. Molecular nutrition & food research 2013 Apr 57 (4): 607-27. Figueiredo Jane C, Levine A Joan, Crott Jimmy W, Baurley James, Haile Robert |
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Apr 32 (10): 1031-9. Rosmarin Dan, Palles Claire, Church David, Domingo Enric, Jones Angela, Johnstone Elaine, Wang Haitao, Love Sharon, Julier Patrick, Scudder Claire, Nicholson George, Gonzalez-Neira Anna, Martin Miguel, Sargent Daniel, Green Erin, McLeod Howard, Zanger Ulrich M, Schwab Matthias, Braun Michael, Seymour Matthew, Thompson Lindsay, Lacas Benjamin, Boige Valérie, Ribelles Nuria, Afzal Shoaib, Enghusen Henrik, Jensen Søren Astrup, Etienne-Grimaldi Marie-Christine, Milano Gérard, Wadelius Mia, Glimelius Bengt, Garmo Hans, Gusella Milena, Lecomte Thierry, Laurent-Puig Pierre, Martinez-Balibrea Eva, Sharma Rohini, Garcia-Foncillas Jesus, Kleibl Zdenek, Morel Alain, Pignon Jean-Pierre, Midgley Rachel, Kerr David, Tomlinson I |
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS. Gut 2015 Jan 64 (1): 111-20. Rosmarin Dan, Palles Claire, Pagnamenta Alistair, Kaur Kulvinder, Pita Guillermo, Martin Miguel, Domingo Enric, Jones Angela, Howarth Kimberley, Freeman-Mills Luke, Johnstone Elaine, Wang Haitao, Love Sharon, Scudder Claire, Julier Patrick, Fernández-Rozadilla Ceres, Ruiz-Ponte Clara, Carracedo Angel, Castellvi-Bel Sergi, Castells Antoni, Gonzalez-Neira Anna, Taylor Jenny, Kerr Rachel, Kerr David, Tomlinson I |
Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism. Epigenetics 2014 Apr 9 (4): 621-33. Coppedè Fabio, Migheli Francesca, Lopomo Angela, Failli Alessandra, Legitimo Annalisa, Consolini Rita, Fontanini Gabriella, Sensi Elisa, Servadio Adele, Seccia Massimo, Zocco Giuseppe, Chiarugi Massimo, Spisni Roberto, Migliore Luc |
Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study. Cancer 2015 Jun . Cheng Ting-Yuan David, Makar Karen W, Neuhouser Marian L, Miller Joshua W, Song Xiaoling, Brown Elissa C, Beresford Shirley A A, Zheng Yingye, Poole Elizabeth M, Galbraith Rachel L, Duggan David J, Habermann Nina, Bailey Lynn B, Maneval David R, Caudill Marie A, Toriola Adetunji T, Green Ralph, Ulrich Cornelia |
Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer. Oncotarget 2015 Mar 6 (8): 6422-30. García-González Xandra, Cortejoso Lucía, García María I, García-Alfonso Pilar, Robles Luis, Grávalos Cristina, González-Haba Eva, Marta Pellicer, Sanjurjo María, López-Fernández Luis |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World journal of gastroenterology 2017 Aug 23 (32): 5913-5924. Ntavatzikos Anastasios, Spathis Aris, Patapis Paul, Machairas Nikolaos, Peros George, Konstantoudakis Stefanos, Leventakou Danai, Panayiotides Ioannis G, Karakitsos Petros, Koumarianou An |
Identification of new SNPs associated with severe toxicity to capecitabine. Pharmacological research 2017 Mar 120 133-137. Pellicer Marta, García-González Xandra, García María I, Robles Luis, Grávalos Cristina, García-Alfonso Pilar, Pachón Vanessa, Longo Federico, Martínez Virginia, Blanco Carolina, Iglesias Irene, Sanjurjo María, López-Fernández Luis |
Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer. Drug metabolism and personalized therapy 2017 12 32 (4): 209-218. Castro-Rojas Carlos A, Esparza-Mota Antonio R, Hernandez-Cabrera Francisco, Romero-Diaz Viktor J, Gonzalez-Guerrero Juan F, Maldonado-Garza Hector, Garcia-Gonzalez Irma S, Buenaventura-Cisneros Sergio, Sanchez-Lopez Josefina Y, Ortiz-Lopez Rocio, Camacho-Morales Alberto, Barboza-Quintana Oralia, Rojas-Martinez Augus |
Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression. Oncotarget 2017 Sep 8 (43): 74312-74319. Chen Qi, Mao Yong, Meng Fanyi, Wang Lei, Zhang Hongjian, Wang Weipeng, Hua Do |
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov . Abad A, Martínez-Balibrea E, Viéitez J M, Alonso-Orduña V, García Alfonso P, Manzano J L, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda |
Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features. World journal of gastroenterology 2017 Oct 23 (37): 6854-6867. Marques Diego, Ferreira-Costa Layse Raynara, Ferreira-Costa Lorenna Larissa, Correa Romualdo da Silva, Borges Aline Maciel Pinheiro, Ito Fernanda Ribeiro, Ramos Carlos Cesar de Oliveira, Bortolin Raul Hernandes, Luchessi André Ducati, Ribeiro-Dos-Santos Ândrea, Santos Sidney, Silbiger Vivian Noguei |
Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. Drug metabolism and personalized therapy 2018 Sep . Zawiah Mohammed, Yousef Al-Motassem, Kadi Taha, Yousef Mohammed, Majdalawi Khalil, Al-Yacoub Shorouq, Al-Hiary Rasha, Tantawi Dua'a, Mukred Ramzi, Ajaj Abdel Rahm |
TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A gene mutation in Mexican colorectal cancer patients. Acta biochimica Polonica 2018 65 (2): 227-234. Gallegos-Arreola Martha Patricia, Zúñiga-González Guillermo Moisés, Sánchez-López Josefina Yoaly, Cruz Alondra Yeraldi Naranjo, Peralta-Leal Valeria, Figuera Luis Eduardo, Puebla-Pérez Ana María, Ronquillo-Carreón Carlos Alberto, Puebla-Mora Ana Gracie |
Pathway analysis of genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a prospectively followed cohort of colorectal cancer patients. Cancer medicine 2018 May . Ose Jennifer, Botma Akke, Balavarca Yesilda, Buck Katharina, Scherer Dominique, Habermann Nina, Beyerle Jolantha, Pfütze Katrin, Seibold Petra, Kap Elisabeth J, Benner Axel, Jansen Lina, Butterbach Katja, Hoffmeister Michael, Brenner Hermann, Ulrich Alexis, Schneider Martin, Chang-Claude Jenny, Burwinkel Barbara, Ulrich Cornelia |
XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer. PloS one 2018 13 (2): e0192316. He Yanjing, Penney Michelle E, Negandhi Amit A, Parfrey Patrick S, Savas Sevtap, Yilmaz Yildiz |
DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients. Journal of personalized medicine 2018 Dec 8 (4): . Amirfallah Arsalan, Kocal Gizem Calibasi, Unal Olcun Umit, Ellidokuz Hulya, Oztop Ilhan, Basbinar Yasem |
Analysis of 12 variants in the development of gastric and colorectal cancers. World journal of gastroenterology 2017 Dec 23 (48): 8533-8543. Cavalcante Giovanna C, Amador Marcos At, Ribeiro Dos Santos André M, Carvalho Darlen C, Andrade Roberta B, Pereira Esdras Eb, Fernandes Marianne R, Costa Danielle F, Santos Ney Pc, Assumpção Paulo P, Ribeiro Dos Santos Ândrea, Santos Sidn |
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World journal of gastrointestinal oncology 2019 Jul 11 (7): 551-566. Ntavatzikos Anastasios, Spathis Aris, Patapis Paul, Machairas Nikolaos, Vourli Georgia, Peros George, Papadopoulos Iordanis, Panayiotides Ioannis, Koumarianou An |
Capecitabine-induced cerebellar toxicity and TYMS pharmacogenetics. Anti-cancer drugs 2019 3 30 (4): 431-434. Saif Muhammad |
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Frontiers in pharmacology 2020 897. De Mattia Elena, Roncato Rossana, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer. Cancer research and treatment 2020 Dec . Dong Si-Qi, Wang Tong-Min, Zhang Jiang-Bo, He Yong-Qiao, Xue Wen-Qiong, Wu Zi-Yi, Yang Da-Wei, Cao Lian-Jing, Huang Jing-Wen, Li Xi-Zhao, Zhang Pei-Fen, Zheng Xiao-Hui, Jia Wei-H |
Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy. Journal of Cancer 2020 11 (22): 6507-6515. Jiang Lu, Li Shuwei, Yuan Ming, Ma Ling, Lin Yu, Zhu Weiyou, Du Haina, Wang Meilin, Chen Tao, Zhu Lingj |
3'-UTR Polymorphisms in Thymidylate Synthase with Colorectal Cancer Prevalence and Prognosis. Journal of personalized medicine 2021 Jun 11 (6): . Jeon Young-Joo, Cho Sung-Hwan, Kim Eo-Jin, Ryu Chang-Soo, Park Han-Sung, Kim Jong-Woo, Lee Jeong-Yong, An Hui-Jeong, Kim Nam-Ke |
DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. Journal of chemotherapy (Florence, Italy) 2022 Sep 1-10. Khalij Yassine, Belaid Imtinen, Chouchane Sana, Amor Dorra, Omezzine Asma, Ben Rejeb Nabila, Ben Ahmed Slim, Bouslama A |
Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer. International journal of molecular sciences 2024 1 25 (1): . Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: